MIRA Pharmaceuticals, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $11,161 |
EBITDA | -5,824 | -1,137 | -1,546 | -1,805 |
EBIT | -1,546 | -2,361 | ||
Net Income | -5,983 | -22,694 | -1,537 | -1,783 |
Net Change In Cash | 0 | 0 | 0 | 11,161 |
Free Cash Flow | -1,135 | -1,096 | -799 | -1,630 |
Cash | 6,346 | 2,641 | 730 | 1,206 |
Basic Shares | 23,694 | 19,274 | 16,986 | 16,645 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -8,526 | |||
EBITDA | -10,493 | -8,018 | -8,526 | -7,047 |
EBIT | -8,018 | -11,982 | -7,047 | |
Net Income | -10,442 | -7,852 | -11,982 | -7,058 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -4,661 | -5,560 | -4,532 | -5,604 |
Cash | 6,346 | 2,832 | 4,602 | 350 |
Basic Shares | 23,694 | 15,444 | 18,566 | 14,745 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.14 |
2025-09-30 | -$1.18 |
2025-06-30 | -$0.09 |
2025-03-31 | -$0.11 |
